Difference between revisions of "John Sleeth"

Line 21: Line 21:
 
Due to a major scandal in [[3023]], when a batch of synthetic molecular antibodies produced by Baker Pharmaceuticals become toxic and killed over a hundred [[Lyran Commonwealth Armed Forces]] soliders, Sleeth's company faced serious financial difficulties arises from the subsequent lawsuit and large damages payout.  
 
Due to a major scandal in [[3023]], when a batch of synthetic molecular antibodies produced by Baker Pharmaceuticals become toxic and killed over a hundred [[Lyran Commonwealth Armed Forces]] soliders, Sleeth's company faced serious financial difficulties arises from the subsequent lawsuit and large damages payout.  
  
Baker's distressed state caused [[Nashan Diversified]] to attempt a takeover of the company, which Sleeth tried to resisted, by seeking to personally acquire all Baker's publicly owned stock at a higher price than was being offered by Nashan.<ref name=HSLC></ref>
+
Baker's distressed state caused [[Nashan Diversified]] to attempt a takeover of the company, which Sleeth tried to resisted, by seeking to personally acquire all Baker's publicly owned stock at a higher price than was being offered by Nashan.<ref name=HSLC></ref> Nashan was however eventually able to overcome Sleeth's effort, and acquire Baker for itself.<ref name=HHS>''Handbook: House Steiner'', Page 134</ref>
  
 
==References==
 
==References==
Line 27: Line 27:
  
 
==Bibliography==
 
==Bibliography==
 +
* ''[[Handbook: House Steiner]]''
 
* ''[[House Steiner (The Lyran Commonwealth)]]''
 
* ''[[House Steiner (The Lyran Commonwealth)]]''
  
 
[[Category:Lyran Commonwealth Characters|Sleeth, John]]
 
[[Category:Lyran Commonwealth Characters|Sleeth, John]]

Revision as of 20:12, 25 November 2023

John Sleeth
Personal
AffiliationLyran Commonwealth
Career
ProfessionCorporate executive

John Sleeth was the head of Baker Pharmaceuticals, a pharmaceutical company in the Lyran Commonwealth, as of 3024.[1]

History

Due to a major scandal in 3023, when a batch of synthetic molecular antibodies produced by Baker Pharmaceuticals become toxic and killed over a hundred Lyran Commonwealth Armed Forces soliders, Sleeth's company faced serious financial difficulties arises from the subsequent lawsuit and large damages payout.

Baker's distressed state caused Nashan Diversified to attempt a takeover of the company, which Sleeth tried to resisted, by seeking to personally acquire all Baker's publicly owned stock at a higher price than was being offered by Nashan.[1] Nashan was however eventually able to overcome Sleeth's effort, and acquire Baker for itself.[2]

References

  1. 1.0 1.1 House Steiner (The Lyran Commonwealth), Page 142
  2. Handbook: House Steiner, Page 134

Bibliography